The Indianapolis Business Journal reports that Eli Lilly & Co. Chief Executive Sidney Taurel told CNBC this morning the Indianapolis-based drug company has no plans to slash its global sales force.
Taurel said there has been “some reduction, some reorganization” in Lilly’s sales force, but added, “we don’t see major decreases.”
The IBJ Daily Report adds that Pfizer, the world’s largest drugmaker, said recently it would cut 20 percent of its U.S. and European sales forces.
No comments:
Post a Comment